Nina Wagner-Johnston

Associate Professor

19992020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology

Wierda, W. G., Byrd, J. C., Abramson, J. S., Bilgrami, S. F., Bociek, G., Brander, D., Brown, J., Chanan-Khan, A. A., Chavez, J. C., Coutre, S. E., Davis, R. S., Fletcher, C. D., Hill, B., Kahl, B. S., Kamdar, M., Kaplan, L. D., Khan, N., Kipps, T. J., Lim, M. S., Ma, S. & 10 others, Malek, S., Mato, A., Mosse, C., Shadman, M., Siddiqi, T., Stephens, D., Sundaram, S., Wagner, N., Dwyer, M. & Sundar, H., Feb 1 2020, In : Journal of the National Comprehensive Cancer Network : JNCCN. 18, 2, p. 185-217 33 p.

Research output: Contribution to journalArticle

Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure

Ayers, E. C., Li, S., Medeiros, L. J., Bond, D. A., Maddocks, K. J., Torka, P., Mier Hicks, A., Curry, M., Wagner-Johnston, N. D., Karmali, R., Behdad, A., Fakhri, B., Kahl, B. S., Churnetski, M. C., Cohen, J. B., Reddy, N. M., Modi, D., Ramchandren, R., Howlett, C., Leslie, L. A. & 20 others, Cytryn, S., Diefenbach, C. S., Faramand, R., Chavez, J. C., Olszewski, A. J., Liu, Y., Barta, S. K., Mukhija, D., Hill, B. T., Ma, H., Amengual, J. E., Nathan, S., Assouline, S. E., Orellana-Noia, V. M., Portell, C. A., Chandar, A., David, K. A., Giri, A., Hess, B. T. & Landsburg, D. J., Jan 15 2020, In : Cancer. 126, 2, p. 293-303 11 p.

Research output: Contribution to journalArticle

Poor outcomes for double-hit lymphoma patients treated with curative-intent second-line immunochemotherapy following failure of intensive front-line immunochemotherapy

Landsburg, D. J., Ayers, E. C., Bond, D. A., Maddocks, K. J., Karmali, R., Behdad, A., Curry, M., Wagner-Johnston, N. D., Modi, D., Ramchandren, R., Assouline, S. E., Faramand, R., Chavez, J. C., Torka, P., Mier Hicks, A., Medeiros, L. J. & Li, S., Apr 1 2020, In : British journal of haematology. 189, 2, p. 313-317 5 p.

Research output: Contribution to journalArticle

Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL

Awasthi, R., Pacaud, L., Waldron, E., Tam, C. S., Jäger, U., Borchmann, P., Jaglowski, S., Foley, S. R., Van Besien, K., Wagner-Johnston, N. D., Kersten, M. J., Schuster, S. J., Salles, G., Maziarz, R. T., Anak, Ö., Del Corral, C., Chu, J., Gershgorin, I., Pruteanu-Malinici, I., Chakraborty, A. & 2 others, Mueller, K. T. & Waller, E. K., Feb 11 2020, In : Blood Advances. 4, 3, p. 560-572 13 p.

Research output: Contribution to journalArticle

Open Access
2019

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019

Wierda, W. G., Byrd, J. C., Abramson, J. S., Bilgrami, S. F., Bociek, G., Brander, D., Brown, J., Chanan-Khan, A. A., Chavez, J. C., Coutre, S. E., Davis, R. S., Fletcher, C. D., Hill, B., Kahl, B. S., Kamdar, M., Kaplan, L. D., Khan, N., Kipps, T. J., Ma, S., Malek, S. & 9 others, Mato, A., Mosse, C., Neppalli, V. T., Shadman, M., Siddiqi, T., Stephens, D., Wagner, N., Dwyer, M. A. & Sundar, H., Jan 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 1, p. 12-20 9 p.

Research output: Contribution to journalArticle

Correction: First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL (Oncotarget(2018) 9 (13023 -13035) DOI: 10.18632/oncotarget.24310)

Byrd, J. C., Smith, S., Wagner-Johnston, N., Sharman, J., Chen, A. I., Advani, R., Augustson, B., Marlton, P., Renee Commerford, S., Okrah, K., Liu, L., Murray, E., Penuel, E., Ward, A. F. & Flinn, I. W., Jan 1 2019, In : Oncotarget. 10, 38, p. 3827-3830 4 p.

Research output: Contribution to journalComment/debate

Open Access

Dose-adjusted EPOCH-R compared with R-CHOP as frontline therapy for diffuse large B-cell lymphoma: Clinical outcomes of the Phase III intergroup trial alliance/CALGB 50303

Bartlett, N. L., Wilson, W. H., Jung, S. H., Hsi, E. D., Maurer, M. J., Pederson, L. D., Polley, M. Y. C., Pitcher, B. N., Cheson, B. D., Kahl, B. S., Friedberg, J. W., Staudt, L. M., Wagner-Johnston, N. D., Blum, K. A., Abramson, J. S., Reddy, N. M., Winter, J. N., Chang, J. E., Gopal, A. K., Chadburn, A. & 6 others, Mathew, S., Fisher, R. I., Richards, K. L., Schoder, H., Zelenetz, A. D. & Leonard, J. P., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1790-1799 10 p.

Research output: Contribution to journalArticle

DYNAMO: A Phase II study of duvelisib (IPI-145) in patients with refractory indolent non-hodgkin lymphoma

Flinn, I. W., Miller, C. B., Ardeshna, K. M., Tetreault, S., Assouline, S. E., Mayer, J., Merli, M., Lunin, S. D., Pettitt, A. R., Nagy, Z., Tournilhac, O., Abou-Nassar, K. E., Crump, M., Jacobsen, E. D., De Vos, S., Kelly, V. M., Shi, W., Steelman, L., Le, N. D., Weaver, D. T. & 3 others, Lustgarten, S., Wagner-Johnston, N. D. & Zinzani, P. L., Jan 1 2019, In : Journal of Clinical Oncology. 37, 11, p. 912-922 11 p.

Research output: Contribution to journalArticle

Open Access

Efficacy and safety of the dual SYK/JAK inhibitor cerdulatinib in patients with relapsed or refractory B-cell malignancies: Results of a phase I study

Hamlin, P. A., Flinn, I. W., Wagner-Johnston, N., Burger, J. A., Coffey, G. P., Conley, P. B., Michelson, G., Leeds, J. M., Der, K., Kim, Y., Sabalvaro-Torres, A., Birrell, M., Pandey, A., Curnutte, J. T. & Patel, M. R., Apr 2019, In : American journal of hematology. 94, 4, p. E90-E93

Research output: Contribution to journalLetter

Open Access

Implication of Rituximab Infusion Reactions on Clinical Outcomes in Patients With Diffuse Large B-cell Lymphoma: A Single Institution Experience

Patel, D. A., Johanns, T. M., Trinkaus, K., Bartlett, N. L., Wagner-Johnston, N. & Cashen, A. F., Jan 1 2019, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance)

Rosenbaum, C. A., Jung, S. H., Pitcher, B., Bartlett, N. L., Smith, S. M., Hsi, E., Wagner-Johnston, N., Thomas, S. P., Leonard, J. P. & Cheson, B. D., Apr 2019, In : British journal of haematology. 185, 1, p. 53-64 12 p.

Research output: Contribution to journalArticle

Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance)

Blum, K. A., Polley, M. Y., Jung, S. H., Dockter, T. J., Anderson, S., Hsi, E. D., Wagner-Johnston, N., Christian, B., Atkins, J., Cheson, B. D., Leonard, J. P. & Bartlett, N. L., Oct 1 2019, In : Cancer. 125, 19, p. 3378-3389 12 p.

Research output: Contribution to journalArticle

Somatosensory predictors of response to pregabalin in painful chemotherapy-induced peripheral neuropathy: A randomized, placebo-controlled, crossover study

Hincker, A., Frey, K., Rao, L., Wagner-Johnston, N., Abdallah, A. B., Tan, B., Amin, M., Wildes, T., Shah, R., Karlsson, P., Bakos, K., Kosicka, K., Kagan, L. & Haroutounian, S., Aug 2019, In : Pain. 160, 8, p. 1835-1846 12 p.

Research output: Contribution to journalArticle

Survival outcomes of younger patients with mantle cell lymphoma treated in the rituximab era

Gerson, J. N., Handorf, E., Villa, D., Gerrie, A. S., Chapani, P., Li, S., Jeffrey Medeiros, L., Wang, M. I., Cohen, J. B., Calzada, O., Churnetski, M. C., Hill, B. T., Sawalha, Y., Hernandez-Ilizaliturri, F. J., Kothari, S., Vose, J. M., Bast, M. A., Fenske, T. S., Gari, S. N. R., Maddocks, K. J. & 30 others, Bond, D., Bachanova, V., Kolla, B., Chavez, J., Shah, B., Lansigan, F., Burns, T. F., Donovan, A. M., Wagner-Johnston, N., Messmer, M., Mehta, A., Anderson, J. K., Reddy, N., Kovach, A. E., Landsburg, D. J., Glenn, M., Inwards, D. J., Karmali, R., Kaplan, J. B., Caimi, P. F., Rajguru, S., Evens, A., Klein, A., Umyarova, E., Pulluri, B., Amengual, J. E., Lue, J. K., Diefenbach, C., Fisher, R. I. & Barta, S. K., Jan 1 2019, In : Journal of Clinical Oncology. 37, 6, p. 471-480 10 p.

Research output: Contribution to journalArticle

2018

CALGB 50604: Risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET

Straus, D. J., Jung, S. H., Pitcher, B., Kostakoglu, L., Grecula, J. C., Hsi, E. D., Schöder, H., Popplewell, L. L., Chang, J. E., Moskowitz, C. H., Wagner-Johnston, N., Leonard, J. P., Friedberg, J. W., Kahl, B. S., Cheson, B. D. & Bartlett, N. L., Sep 6 2018, In : Blood. 132, 10, p. 1013-1021 9 p.

Research output: Contribution to journalArticle

First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL

Byrd, J. C., Smith, S., Wagner-Johnston, N., Sharman, J., Chen, A. I., Advani, R., Augustson, B., Marlton, P., Commerford, S. R., Okrah, K., Liu, L., Murray, E., Penuel, E., Ward, A. F. & Flinn, I. W., Jan 1 2018, In : Oncotarget. 9, 16, p. 13023-13035 13 p.

Research output: Contribution to journalArticle

Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial

Brown, J. R., Hamadani, M., Hayslip, J., Janssens, A., Wagner-Johnston, N., Ottmann, O., Arnason, J., Tilly, H., Millenson, M., Offner, F., Gabrail, N. Y., Ganguly, S., Ailawadh, S., Kasar, S., Kater, A. P., Doorduijn, J. K., Gao, L., Lager, J. J., Wu, B., Egile, C. & 1 others, Kersten, M. J., Apr 2018, In : The Lancet Haematology. 5, 4, p. e170-e180

Research output: Contribution to journalArticle

2017

A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia

Garzon, R., Savona, M., Baz, R., Andreeff, M., Gabrail, N., Gutierrez, M., Savoie, L., Mau-Sorensen, P. M., Wagner-Johnston, N., Yee, K., Unger, T. J., Saint-Martin, J. R., Carlson, R., Rashal, T., Kashyap, T., Klebanov, B., Shacham, S., Kauffman, M. & Stone, R., Jun 15 2017, In : Blood. 129, 24, p. 3165-3174 10 p.

Research output: Contribution to journalArticle

A phase 2/3 multicenter, randomized, open-label study to compare the efficacy and safety of lenalidomide versus investigator's choice in patients with relapsed or refractory diffuse large B-cell lymphoma

Czuczman, M. S., Trněný, M., Davies, A., Rule, S., Linton, K. M., Wagner-Johnston, N., Gascoyne, R. D., Slack, G. W., Brousset, P., Eberhard, D. A., Hernandez-Ilizaliturri, F. J., Salles, G., Witzig, T. E., Zinzani, P. L., Wright, G. W., Staudt, L. M., Yang, Y., Williams, P. M., Lih, C. J., Russo, J. & 5 others, Thakurta, A., Hagner, P., Fustier, P., Song, D. & Lewis, I. D., Aug 1 2017, In : Clinical Cancer Research. 23, 15, p. 4127-4137 11 p.

Research output: Contribution to journalArticle

A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma

Maly, J. J., Christian, B. A., Zhu, X., Wei, L., Sexton, J. L., Jaglowski, S. M., Devine, S. M., Fehniger, T. A., Wagner-Johnston, N., Phelps, M. A., Bartlett, N. L. & Blum, K. A., Jun 1 2017, In : Clinical Lymphoma, Myeloma and Leukemia. 17, 6, p. 347-353 7 p.

Research output: Contribution to journalArticle

Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial

Jones, J. A., Robak, T., Brown, J. R., Awan, F. T., Badoux, X., Coutre, S., Loscertales, J., Taylor, K., Vandenberghe, E., Wach, M., Wagner-Johnston, N., Ysebaert, L., Dreiling, L., Dubowy, R., Xing, G., Flinn, I. W. & Owen, C., Mar 1 2017, In : The Lancet Haematology. 4, 3, p. e114-e126

Research output: Contribution to journalArticle

Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: A subgroup analysis of a phase 2 study

Salles, G., Schuster, S. J., De Vos, S., Wagner-Johnston, N. D., Viardot, A., Blum, K. A., Flowers, C. R., Jurczak, W. J., Flinn, I. W., Kahl, B. S., Martin, P., Kim, Y., Shreay, S., Will, M., Sorensen, B., Breuleux, M., Zinzani, P. L. & Gopal, A. K., Mar 31 2017, In : Haematologica. 102, 4, p. e156-e159

Research output: Contribution to journalLetter

Hairy cell Leukemia, Version 2.2018: Clinical practice guidelines in oncology

Wierda, W. G., Byrd, J. C., Abramson, J. S., Bhat, S., Bociek, G., Brander, D., Brown, J., Chanan-Khan, A., Coutre, S. E., Davis, R. S., Fletcher, C. D., Hill, B., Kahl, B. S., Kamdar, M., Kaplan, L. D., Khan, N., Kipps, T. J., Lancet, J., Ma, S., Malek, S. & 6 others, Mosse, C., Shadman, M., Siddiqi, T., Stephens, D., Wagner, N. & Zelenetz, A. D., Nov 1 2017, In : JNCCN Journal of the National Comprehensive Cancer Network. 15, 11, p. 1414-1427 14 p.

Research output: Contribution to journalReview article

High frequency of identical clonal immunoglobulin DNA in pre-treatment tumor and plasma from untreated patients with HIV-associated lymphoma: prospective multicenter trial of the AIDS malignancies consortium (AMC 064)

Wagner-Johnston, N., Lensing, S., Noy, A., Ratner, L., Henry, D., Lee, J. Y., Silver, S., Faham, M. & Ambinder, R. F., May 15 2017, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-4 4 p.

Research output: Contribution to journalArticle

Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study

Goyal, S., Oak, E., Luo, J., Cashen, A. F., Carson, K., Fehniger, T., DiPersio, J., Bartlett, N. L. & Wagner-Johnston, N. D., Jun 9 2017, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-6 6 p.

Research output: Contribution to journalArticle

Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients

Schoch, L. K., Asiama, A., Zahurak, M., Shanbhag, S. P., Hurtt, J., Sawyer, K., Swinnen, L., Wagner-Johnston, N., Jones, R. J., Ambinder, R. F. & Gladstone, D., Dec 13 2017, (Accepted/In press) In : Cancer Chemotherapy and Pharmacology. p. 1-8 8 p.

Research output: Contribution to journalArticle

Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials

Smith, S. M., Pitcher, B. N., Jung, S. H., Bartlett, N. L., Wagner-Johnston, N., Park, S. I., Richards, K. L., Cashen, A. F., Jaslowski, A., Smith, S. E., Cheson, B. D., Hsi, E. & Leonard, J. P., Apr 1 2017, In : The Lancet Haematology. 4, 4, p. e176-e182

Research output: Contribution to journalArticle

2016

A phase 2 study of inotuzumab ozogamicin in patients with indolent B-cell non-Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy

Goy, A., Forero, A., Wagner-Johnston, N., Christopher Ehmann, W., Tsai, M., Hatake, K., Ananthakrishnan, R., Volkert, A., Vandendries, E. & Ogura, M., Aug 1 2016, In : British Journal of Haematology. 174, 4, p. 571-581 11 p.

Research output: Contribution to journalArticle

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505)

Pachman, D. R., Qin, R., Seisler, D., Smith, E. M. L., Kaggal, S., Novotny, P., Ruddy, K. J., Lafky, J. M., Ta, L. E., Beutler, A. S., Wagner-Johnston, N., Staff, N. P., Grothey, A., Dougherty, P. M., Cavaletti, G. & Loprinzi, C. L., Aug 18 2016, (Accepted/In press) In : Supportive Care in Cancer. p. 1-10 10 p.

Research output: Contribution to journalArticle

MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy

Zimmerman, C., Atherton, P. J., Pachman, D., Seisler, D., Wagner-Johnston, N., Dakhil, S., Lafky, J. M., Qin, R., Grothey, A. & Loprinzi, C. L., Mar 1 2016, In : Supportive Care in Cancer. 24, 3, p. 1071-1078 8 p.

Research output: Contribution to journalArticle

Outcomes with R-CEOP for R-CHOP-ineligible patients with diffuse large B-cell lymphoma are highly dependent on cell of origin defined by Hans criteria

Rashidi, A., Oak, E., Carson, K. R., Wagner-Johnston, N. D., Kreisel, F. & Bartlett, N. L., May 3 2016, In : Leukemia and Lymphoma. 57, 5, p. 1191-1193 3 p.

Research output: Contribution to journalLetter

Postibrutinib outcomes in patients with mantle cell lymphoma

Martin, P., Maddocks, K., Leonard, J. P., Ruan, J., Goy, A., Wagner-Johnston, N., Rule, S., Advani, R., Iberri, D., Phillips, T., Spurgeon, S., Kozin, E., Noto, K., Chen, Z., Jurczak, W., Auer, R., Chmielowska, E., Stilgenbauer, S., Bloehdorn, J., Portell, C. & 7 others, Williams, M. E., Dreyling, M., Barr, P. M., Chen-Kiang, S., DiLiberto, M., Furman, R. R. & Blum, K. A., Mar 24 2016, In : Blood. 127, 12, p. 1559-1563 5 p.

Research output: Contribution to journalArticle

Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched sibling donors: A center for international blood and marrow transplant research analysis

Ghosh, N., Karmali, R., Rocha, V., Ahn, K. W., DiGilio, A., Hari, P. N., Bachanova, V., Bacher, U., Dahi, P., De Lima, M., D'Souza, A., Fenske, T. S., Ganguly, S., Kharfan-Dabaja, M. A., Prestidge, T. D., Savani, B. N., Smith, S. M., Sureda, A. M., Waller, E. K., Jaglowski, S. & 7 others, Herrera, A. F., Armand, P., Salit, R. B., Wagner-Johnston, N. D., Fuchs, E., Bolaños-Meade, J. & Hamadani, M., Sep 10 2016, In : Journal of Clinical Oncology. 34, 26, p. 3141-3149 9 p.

Research output: Contribution to journalArticle

Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up

Majithia, N., Atherton, P. J., Lafky, J. M., Wagner-Johnston, N., Olson, J., Dakhil, S. R., Perez, E. A., Loprinzi, C. L. & Hines, S. L., Mar 1 2016, In : Supportive Care in Cancer. 24, 3, p. 1219-1226 8 p.

Research output: Contribution to journalArticle

2015

5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial

Wagner-Johnston, N. D., Sloan, J. A., Liu, H., Kearns, A. E., Hines, S. L., Puttabasavaiah, S., Dakhil, S. R., Lafky, J. M., Perez, E. A. & Loprinzi, C. L., Aug 1 2015, In : Cancer. 121, 15, p. 2537-2543 7 p.

Research output: Contribution to journalArticle

AMC 048: Modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma

AIDS Malignancy Consortium, Jul 9 2015, In : Blood. 126, 2, p. 160-166 7 p.

Research output: Contribution to journalArticle

A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma

Wagner-Johnston, N. D., Goy, A., Rodriguez, M. A., Ehmann, W. C., Hamlin, P. A., Radford, J., Thieblemont, C., Suh, C., Sweetenham, J., Huang, Y., Sullivan, S. T., Vandendries, E. R. & Gisselbrecht, C., Oct 3 2015, In : Leukemia and Lymphoma. 56, 10, p. 2863-2869 7 p.

Research output: Contribution to journalArticle

Cancer-related fatigue, version 2.2015

Berger, A. M., Mooney, K., Alvarez-Perez, A., Breitbart, W. S., Carpenter, K. M., Cella, D., Cleeland, C., Dotan, E., Eisenberger, M. A., Escalante, C. P., Jacobsen, P. B., Jankowski, C., LeBlanc, T., Ligibel, J. A., Loggers, E. T., Mandrell, B., Murphy, B. A., Palesh, O., Pirl, W. F., Plaxe, S. C. & 8 others, Riba, M. B., Rugo, H. S., Salvador, C., Wagner, L. I., Wagner-Johnston, N. D., Zachariah, F. J., Bergman, M. A. & Smith, C., Aug 1 2015, In : JNCCN Journal of the National Comprehensive Cancer Network. 13, 8, p. 1012-1039 28 p.

Research output: Contribution to journalReview article

Open Access

Clinical course of oxaliplatin-induced neuropathy: Results from the randomized phase III trial N08CB (Alliance)

Pachman, D. R., Qin, R., Seisler, D. K., Smith, E. M. L., Beutler, A. S., Ta, L. E., Lafky, J. M., Wagner-Johnston, N. D., Ruddy, K. J., Dakhil, S., Staff, N. P., Grothey, A. & Loprinzi, C. L., Oct 20 2015, In : Journal of Clinical Oncology. 33, 30, p. 3416-3422 7 p.

Research output: Contribution to journalArticle

Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma

Carson, K. R., Riedell, P., Lynch, R., Nabhan, C., Wildes, T. M., Liu, W., Ganti, A., Roop, R., Sanfilippo, K. M., O'Brian, K., Liu, J., Bartlett, N. L., Cashen, A., Wagner-Johnston, N., Fehniger, T. A. & Colditz, G. A., May 1 2015, In : Journal of Geriatric Oncology. 6, 3, p. 211-218 8 p.

Research output: Contribution to journalArticle